View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pertuzumab 840 / Trastuzumab 8 / Tamoxifen 20, Breast Cancer, adjuvant, cycle 1
Protocol-ID: 2450 V1.1 (Mini), PERT840/TRAS8/TMXF20, Breast Ca, adj., C1Indication(s)
- Breast Cancer (HER2+, HR+ premenopausal); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 09.10.2024